Emergent BioSolutions (EBS) Tops Q4 EPS by 19c
Tweet
Share
E-mailGet Alerts EBS Hot Sheet
Price: $8.32 -0.83%
Revenue Growth %: +32.0%
Financial Fact:
Interest expense: -2.05M
Today's EPS Names:
PLCE, COE, JVA, More
Revenue Growth %: +32.0%
Financial Fact:
Interest expense: -2.05M
Today's EPS Names:
PLCE, COE, JVA, More
Join SI Premium – FREE
Emergent BioSolutions (NYSE: EBS) reported Q4 EPS of $0.67, $0.19 better than the analyst estimate of $0.48. Revenue for the quarter came in at $151.7 million versus the consensus estimate of $120.45 million.
For earnings history and earnings-related data on Emergent BioSolutions (EBS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- SailPoint Technologies Holdings (SAIL) Tops Q2 EPS by 1c, Offers Guidance
- MIND Technology (MIND) Misses Q1 EPS by 5c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
